BofA/Merrill Lynch Downgrades Dr. Reddy's Laboratories (RDY) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
Dr. Reddys Labs (RDY) Reports Q3 EPS of $0.40
February 14, 2013 6:54 AM ESTDr. Reddys Labs (NYSE: RDY) reported Q3 EPS of $0.40, versus $0.50 reported last year. Revenue for the quarter came in at $522 million, versus $505 million reported last year.
For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.... More
